Berlin chemistry
| Berlin-Chemie AG
|
|
|---|---|
 |
|
| legal form | Corporation |
| founding | 1890 |
| Seat | Berlin , Glienicker Weg 125, Germany |
| management | Reinhard Uppenkamp (CEO) |
| Number of employees | 5,426 (2018) |
| sales | EUR 1.700 billion (2018) |
| Branch | Pharmaceutical industry |
| Website | Berlin-Chemie.de |
The Berlin-Chemie AG is a Berlin pharmaceutical company and since 1992 part of the Italian pharmaceutical company Menarini . According to its own information, Berlin-Chemie took 20th place among German pharmaceutical companies with sales of 1.5 billion euros in 2015.
history
Berlin-Chemie regards the establishment of a factory for laboratory preparations at the Kahlbaum Chemical Factory in Berlin-Adlershof in 1890 as its origin. The first factory was located in the then administrative district of Treptow , Berlin-Adlershof district, Glienicker Weg . In 1927, following a merger with Schering AG , the employees began developing pharmaceuticals .
In the GDR , the Berlin-Chemie was a strong economy based pharmaceutical company with contacts with countries of the CMEA and also to capitalist states. The best- known products from this time were Acesal , Analgin , Berlocombin and many more.
When the state- owned companies were privatized or dissolved after the political change , the Italian Menarini group took over the factory in Berlin including the brand name in 1992 and immediately found a larger market in Eastern Europe .
Products
The company is primarily active in the field of chronic diseases. The focus is on the following product groups:
- Cardiovascular and metabolic therapeutic agents
- Antidiabetic drugs
- Analgesics and anti-inflammatory drugs
- Gastrointestinal therapeutics
- Thyroid therapeutics
- Cough and cold drugs
- Infusion solutions
In February 2013, Berlin-Chemie took over the Priligy brand , a drug against premature ejaculation . Since mid-2013 there has been a media campaign on the topic of premature ejaculation on the Internet and through posters, which many doctors are critical of; According to the imprint of the website in question, nachkommen.de , it is a media contribution by Berlin-Chemie AG.
Since 2015, Berlin-Chemie has been able to manufacture and distribute anti-cancer drugs through a license agreement with the Japanese pharmaceutical manufacturer Chugai .
Web links
Individual evidence
- ↑ a b vfa.de: Berlin Chemie AG
- ↑ Glienicker Weg . In: Berliner Adreßbuch , 1925, IV, p. 1796.
- ^ Adlershof> Glienicker Weg 149–151 and 155–181> Schering-Kahlbaum AG . In: Berliner Adreßbuch , 1935, IV, p. 1880.
- ↑ Nicola Kuhrt: Premature ejaculation: pharmaceutical company invents mass ailments . Mirror online. July 17, 2013. Retrieved July 17, 2013.
- ↑ Chugai and Berlin-Chemie conclude global license agreement for anti-cancer drugs at www.berlin-chemie.de, accessed on December 12, 2016.
Coordinates: 52 ° 26 ′ 0.6 ″ N , 13 ° 33 ′ 25.2 ″ E